MeSH term
Frequency | Condition_Probility | Animals | 6 | 0.0 |
*DNA Repair Enzymes | 10 | 10.0 |
Female | 21 | 0.0 |
Male | 18 | 0.0 |
Mice | 6 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Mice, Mutant Strains | 2 | 0.0 |
Microsatellite Repeats | 6 | 0.0 |
Molecular Sequence Data | 13 | 0.0 |
Research Support, Non-U.S. Gov't | 29 | 0.0 |
Sequence Analysis | 2 | 0.0 |
DNA Mutational Analysis | 4 | 0.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
*DNA-Binding Proteins | 13 | 0.0 |
Germ-Line Mutation/*genetics | 5 | 3.0 |
Humans | 43 | 0.0 |
Middle Aged | 21 | 0.0 |
Neoplasm Proteins/*genetics | 4 | 0.0 |
Pedigree | 7 | 0.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Proto-Oncogene Proteins/*genetics | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 20 | 0.0 |
Tumor Cells, Cultured | 4 | 0.0 |
*Base Pair Mismatch | 9 | 9.0 |
Blotting, Western | 2 | 0.0 |
*DNA Repair | 10 | 1.0 |
Disease Progression | 3 | 0.0 |
Immunohistochemistry | 4 | 0.0 |
Microsatellite Repeats/genetics | 5 | 1.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
*Adenosinetriphosphatase | 8 | 10.0 |
Colorectal Neoplasms, Hereditary Nonpolyposis/genetics | 3 | 6.0 |
Comparative Study | 6 | 0.0 |
DNA Repair/*genetics | 14 | 4.0 |
Gene Expression | 3 | 0.0 |
Mutation | 7 | 0.0 |
Neoplasm Proteins/biosynthesis/genetics | 2 | 1.0 |
Proto-Oncogene Proteins/biosynthesis/genetics | 2 | 2.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 6 | 0.0 |
Age of Onset | 2 | 0.0 |
Base Pair Mismatch/*genetics | 6 | 10.0 |
English Abstract | 2 | 0.0 |
Alleles | 3 | 0.0 |
Base Sequence | 7 | 0.0 |
Carrier Proteins/*genetics | 3 | 0.0 |
Colorectal Neoplasms, Hereditary Nonpolyposis/*genetics | 8 | 8.0 |
Genetic Screening | 5 | 0.0 |
Mutation/*genetics | 2 | 0.0 |
Neoplasm Proteins/genetics | 4 | 0.0 |
Proto-Oncogene Proteins/genetics | 2 | 0.0 |
United States | 2 | 0.0 |
*Saccharomyces cerevisiae Proteins | 4 | 0.0 |
Time Factors | 2 | 0.0 |
Adult | 12 | 0.0 |
Base Pair Mismatch | 3 | 1.0 |
*Neoplasm Proteins | 4 | 0.0 |
Adolescent | 2 | 0.0 |
Aged | 10 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Child | 3 | 0.0 |
Prognosis | 3 | 0.0 |
*DNA Damage | 2 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
*Mutation | 7 | 0.0 |
BRCA2 Protein | 2 | 0.0 |
*Genetic Predisposition to Disease | 2 | 0.0 |
Genetic Markers/genetics | 2 | 0.0 |
Genome, Human | 2 | 0.0 |
*Germ-Line Mutation | 3 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Mice, Inbred Strains | 2 | 0.0 |
Microsatellite Repeats/*genetics | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Colorectal Neoplasms, Hereditary Nonpolyposis/*diagnosis/genetics | 2 | 100.0 |
DNA/genetics | 2 | 0.0 |
Genetic Techniques | 2 | 2.0 |
Genotype | 4 | 0.0 |
Mutation/genetics | 2 | 0.0 |
Phenotype | 6 | 0.0 |
Risk Factors | 2 | 0.0 |
DNA Repair/genetics | 4 | 2.0 |
*Genetic Screening | 2 | 1.0 |
DNA, Satellite/genetics | 2 | 1.0 |
DNA-Binding Proteins/*genetics | 3 | 0.0 |
Fungal Proteins/*genetics | 5 | 4.0 |
Gene Deletion | 2 | 0.0 |
Genetic Complementation Test | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
Saccharomyces cerevisiae/*genetics | 2 | 1.0 |
*Carrier Proteins | 5 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Proteins/genetics | 3 | 0.0 |
DNA Repair | 4 | 0.0 |
Ultraviolet Rays | 2 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Germ-Line Mutation/genetics | 4 | 5.0 |
Proteins/*genetics | 2 | 0.0 |
Fungal Proteins/genetics | 2 | 1.0 |
*Genes, Fungal | 4 | 3.0 |
Sequence Deletion | 2 | 0.0 |
History, 19th Century | 2 | 6.0 |
Mutagenesis | 2 | 0.0 |
*Repetitive Sequences, Nucleic Acid | 3 | 0.0 |
DNA, Fungal/genetics | 2 | 3.0 |
Diagnosis, Differential | 2 | 0.0 |
Plasmids | 2 | 0.0 |
